NEW YORK, NY / ACCESS Newswire / February 24, 2025 / If you suffered a loss on your TransMedics Group, Inc. (NASDAQ:TMDX) investment and want to ...
Media are invited to join Marc G. Serré, Member of Parliament for Nickel Belt, alongside Douglas Gervais, Mayor of Espanola for the ...
Beyond analysts' top -and-bottom-line estimates for TransMedics (TMDX), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the ...
In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on TransMedics Group (TMDX – Research Report), with a ...
Van ECK Associates Corp grew its holdings in TransMedics Group, Inc. (NASDAQ:TMDX – Free Report) by 102.3% in the fourth ...
TransMedics is revolutionizing organ transplant therapy with its FDA-approved Organ Care System. See why I rate TMDX stock as ...
Analysts predict an EPS of $0.22 and revenue of approximately $109.5 million for the upcoming quarterly report. Legal ...
The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts ...
About Robbins LLP : A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LL have been dedicated to helping shareholders recover losses, improve corporate governance ...
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of TransMedics Group, Inc. between February 28, 2023 and January 10, 2025, both dates inclusive (the "Class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback